MedPath

Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

Not Applicable
Completed
Conditions
Kidney Stones
Interventions
Device: Stonebreaker
Device: Lithoclast Select
Device: Cyberwand
Registration Number
NCT00952315
Lead Sponsor
Indiana Kidney Stone Institute
Brief Summary

The investigators plan to compare three different devices that are used to break up large kidney stones during surgery for removal to see if one is faster or more efficient than the others.

Detailed Description

Large kidney stones can be removed by a surgical procedure where a small puncture is made through the back into the kidney (percutaneous nephrolithotomy or PNL) but the stones usually need to be broken into smaller pieces before they can be removed through the small surgical incision. There are a number of FDA approved devices commercially available used to break up the stones including pneumatic, ultrasonic, and a combination of the two. Each technology has advantages and disadvantages.

In the last few years there have been new, improved versions of these devices introduced. These improved versions have addressed previous issues of probes clogging or breaking and cumbersome handpiece design. These include the Cyberwand (Cybersonics, Erie, PA), a dual probe ultrasonic device, Swiss Lithoclast Select (EMS, Switzerland) combining the pneumatic and ultrasonic modalities, and a novel device by LMA (Gland, Switzerland) called the StoneBreakerTM, a portable pneumatic device powered by CO2 cartridges.

We propose to compare each of these devices in a randomized study to see if one is better than another at removing kidney stones quickly and efficiently.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
270
Inclusion Criteria
  • Scheduled to undergo percutaneous nephrolithotomy for at least one kidney stone measuring 2 cm or greater
  • Stone easily visible/measurable on plain abdominal imaging (KUB) or CT scan preoperatively
  • Age 18 years or older
  • Able to give informed consent
Exclusion Criteria
  • Size of single largest stone less than 2 cm
  • Pregnancy
  • Active urinary tract infection
  • Extracorporeal shockwave lithotripsy within the last three months
  • Complex stone anticipating multiple access sites
  • Stones that are not clearly able to be measured on KUB or CT scan
  • Inability to give informed consent
  • Age less than 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
StonebreakerStonebreakerStonebreaker will be used to break up the kidney stone. Duration will be timed and documented.
Lithoclast SelectLithoclast SelectLithoclast Select will be used to breakup and remove kidney stone. Duration will be timed and documented.
CyberwandCyberwandThe dual probe Cyberwand device will be used to fragment and remove the kidney stone. Duration will be timed and documented.
Primary Outcome Measures
NameTimeMethod
Stone Clearance Time in mm2/Mincollected intraoperatively from the time stone breakage begins to end of stone removal with a stone extraction basket

Clearance rate was calculated by dividing the surface area of the targeted stone (mm2) by the total clearance time (min)

Secondary Outcome Measures
NameTimeMethod
Stone-free After First ProcedurePost-operative Day 1

Number of participants deemed stone-free after initial stone-removal surgery

Secondary Procedure RequiredWithin three days of initial procedure

Number of participants who required a secondary kidney stone removal procedure

Ureteral Stent PlacedIntra-operatively

Participants requiring a ureteral stent to be placed after initial stone removal procedure

Length of StayPost-operatively

Number of days participants were in hospital. Operative day is Day 1.

Post-operative ComplicationsPost-operative Days 2 and 3

Number of participants who experienced surgery-related post-op complications

EBL>400mLIntra-operatively

Number of participants with an estimated blood loss greater than 400mL

Nephrostomy Tube PlacedIntra-operatively

Participants requiring a nephrostomy tube to be placed at the end of the initial stone removal procedure

Use of Other DeviceIntra-operatively

Number of participants in which another stone breakage device was used in addition to the study-assigned lithotrite

RBC TransfusionPost-operatively <24 hours

Number of participants who required a blood transfusion post-operatively

Trial Locations

Locations (10)

Mayo Clinic Scottsdale

🇺🇸

Phoenix, Arizona, United States

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

IU Health Physicians Urology

🇺🇸

Indianapolis, Indiana, United States

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

Mayo Clinic Rochester

🇺🇸

Rochester, Minnesota, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

Johns Hopkins

🇺🇸

Baltimore, Maryland, United States

Duke University

🇺🇸

Durham, North Carolina, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

The University of Western Ontario

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath